Treatment Options for Acute Myelogenous Leukemia (AML) in Children
Acute myelogenous leukemia (AML) is a common type of blood cancer that affects children under the age of 15. It is a cancer where the bone marrow makes a large number of abnormal blood cells. These abnormal cells do not mature properly and crowd out healthy blood cells, leading to a decrease in the production of normal red blood cells, white blood cells, and platelets.
The objective of treating AML in children is to achieve a cure, slow down the progression of the disease, and control symptoms. The treatment options for AML in children typically include chemotherapy and stem cell transplants.
The goal of these treatments is to eliminate as many leukemia cells as possible and achieve remission. Remission means that there are no signs or symptoms of leukemia and that blood tests show no evidence of cancer cells. Achieving remission is an important step towards a potential cure. In some cases, relapse may occur after initial treatment. Relapse therapy becomes critically important for survival in these cases.
It's important to note that the success of treatment can vary from child to child. The 5-year survival rate for children with AML is around 65-70%, which means that about 65-70% of children diagnosed with AML will live for at least another 5 years after their diagnosis. However, survival rates are based on averages and do not take into account recent advances in treatment or individual factors.
Overall, the objective of treating AML in children is to achieve a cure whenever possible, slow down disease progression, and control symptoms to improve the quality of life for affected children.
The treatment plan for AML in children may include combinations of multiple therapies. Treatment options include:
- Chemotherapy: The primary form of treatment for children with AML is chemotherapy. This treatment involves the use of powerful medications to kill cancer cells and prevent their growth. Chemotherapy can help eliminate leukemia cells from the bone marrow and other parts of the body.
- It is often given in cycles, with periods of treatment followed by periods of rest to allow the body to recover.
- Chemotherapy can be given orally (by mouth) or intravenously (through a vein).
- The goal of chemotherapy is to induce remission, which means that no cancer cells can be detected in the body.
- Chemotherapy may cause side effects, such as hair loss, fatigue, and increased susceptibility to infections.
- Targeted Therapy: Targeted therapy uses drugs that specifically target certain molecules or genetic mutations involved in cancer growth. In AML, targeted therapy may involve the use of monoclonal antibodies or tyrosine kinase inhibitors. These medications interfere with specific proteins that play a role in cancer cell growth and survival.
- Stem Cell Transplant: In some cases, a stem cell transplant may be recommended for children with AML. This procedure involves replacing damaged or destroyed bone marrow with healthy stem cells from a donor or the patient’s own body. Stem cell transplants can help restore the body's ability to produce healthy blood cells. Stem cell transplant may also be used to treat relapsed AML.
- Supportive Care: Supportive care is an important part of AML treatment and aims to manage symptoms and improve the overall well-being of the child. It may include measures such as pain management, infection prevention, and nutritional support.
- Clinical trials are research studies that aim to evaluate new treatments or treatment combinations for AML in children. Participating in a clinical trial may provide access to innovative therapies that are not yet widely available. It is important to discuss clinical trial options for your child with the healthcare team. They can review your child’s individual situation and advise whether a clinical trial is an option to consider.
It's important to note that the choice of treatment depends on various factors such as the child's age, overall health, subtype of AML, and response to initial therapy. The intended impact of these treatments is to eliminate or control the leukemia cells, achieve remission, prevent relapse, and improve long-term survival rates for children with AML. It's always recommended to consult with a healthcare professional who specializes in pediatric oncology to discuss the most appropriate treatment options for an individual child's condition.